pimobendan has been researched along with aldosterone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, A; Kanno, N; Kano, R; Kawasaki, M; Kuse, H; Sasaki, Y | 1 |
| Atkins, CE; DeFrancesco, TC; Keene, BW; Lantis, AC; Werre, SR | 1 |
2 other study(ies) available for pimobendan and aldosterone
| Article | Year |
|---|---|
Effects of pimobendan for mitral valve regurgitation in dogs.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiotonic Agents; Catecholamines; Dog Diseases; Dogs; Echocardiography, Doppler; Glomerular Filtration Rate; Male; Mitral Valve Insufficiency; Neurotransmitter Agents; Pyridazines; Renal Circulation; Renin | 2007 |
Effects of furosemide and the combination of furosemide and the labeled dosage of pimobendan on the circulating renin-angiotensin-aldosterone system in clinically normal dogs.
Topics: Administration, Oral; Aldosterone; Animals; Bicarbonates; Blood Chemical Analysis; Blood Pressure; Chlorides; Creatinine; Diuretics; Dogs; Female; Furosemide; Male; Potassium; Pyridazines; Renin-Angiotensin System; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Vasodilator Agents; Weight Loss | 2011 |